KEROS THERAPEUTICS IN
59.67
08-10月-24 14:59:59
15 分の遅延
株式
-0.45
-0.75%
本日の幅
59.56 - 61.00
ISIN
N/A
ソース
NASDAQ
-
Keros Therapeutics Reports Recent Business Highlights and Third Quarter 2022 Financial Results
03 11 2022 06:00:01 提供 Nasdaq GlobeNewswire
-
06 9 2022 07:00:02 提供 Nasdaq GlobeNewswire
-
Keros Therapeutics to Present at the Morgan Stanley 20th Annual Global Healthcare Conference
06 9 2022 07:00:01 提供 Nasdaq GlobeNewswire
-
Keros Therapeutics Reports Recent Business Highlights and Second Quarter 2022 Financial Results
04 8 2022 15:01:00 提供 Nasdaq GlobeNewswire
-
18 5 2022 05:00:00 提供 Nasdaq GlobeNewswire
-
17 5 2022 15:01:00 提供 Nasdaq GlobeNewswire
-
Keros Therapeutics to Present at the 27th Annual Congress of the European Hematology Association
12 5 2022 15:01:00 提供 Nasdaq GlobeNewswire
-
Keros Therapeutics Reports First Quarter 2022 Financial Results
05 5 2022 07:00:03 提供 Nasdaq GlobeNewswire
-
09 3 2022 15:01:00 提供 Nasdaq GlobeNewswire
-
Keros Therapeutics to Present at the 11th Annual SVB Leerink Global Healthcare Conference
11 2 2022 07:00:00 提供 Nasdaq GlobeNewswire
-
Keros Therapeutics Appoints Christopher Rovaldi as Chief Operating Officer
31 1 2022 07:00:02 提供 Nasdaq GlobeNewswire
-
13 12 2021 07:00:01 提供 Nasdaq GlobeNewswire
-
Keros Therapeutics to Present at the Piper Sandler 33rd Annual Virtual Healthcare Conference
22 11 2021 07:00:01 提供 Nasdaq GlobeNewswire
-
15 11 2021 07:00:01 提供 Nasdaq GlobeNewswire